Financial Statement Revise 2024 Reviewed Consolidated Q3 30/09/2024 2024 Reviewed Company Q3 30/09/2024 2024 Reviewed Consolidated Q2 30/06/2024 2024 Reviewed Company Q2 30/06/2024
MD&A Financial Statement Revise 2024 Reviewed Consolidated Q3 30/09/2024 2024 Reviewed Company Q3 30/09/2024 2024 Reviewed Consolidated Q2 30/06/2024 2024 Reviewed Company Q2 30/06
Reviewed Consolidated Q3 30/09/2024 2024 Reviewed Company Q3 30/09/2024 2024 Reviewed Consolidated Q2 30/06/2024 2024 Reviewed Company Q2 30/06/2024 2024 Reviewed Consolidated Q1 31
Statements ( 22 record(s) found) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2024 Reviewed Consolidated Q3 30/09/2024 2024 Reviewed Company Q3 30/09/2024
Statement MD&A Financial Statement Revise 2024 Reviewed Consolidated Q3 30/09/2024 2024 Reviewed Company Q3 30/09/2024 2024 Reviewed Consolidated Q2 30/06/2024 2024 Reviewed Company Q2 30/06
which engage in the business of aesthetic clinic, retailing and wholesaling of cosmetic products Principal office: 160 Kwamwongwan rd., Bangkhen, Muang, Nonthaburi Registered capital (before increase
brand-new company conducting the business of transportation principal equipped with its own container, formerly operating under Thai subsidiary. For Thai subsidiary, there is income and cost specifically
, and business related to FinTech. According to the results of operations in the year 2018, the Company had a net loss in the consolidated financial statements in the amount of 277 million baht, incurred
: 150,000,000 Baht (Revolving) Interest Rate : 7.00 % per annum Term of Loan : 12 months Payment of Interest : Every Month Payment of Principal : Principal of payment at 1 year Collateral : Land and Property
: 50,000,000 Baht Interest Rate : 7 % per year 2 Term of Loan : 2 year Payment of Interest : Every Month Payment of Principal : Due date of payment on contract Collateral : None 4) Objective Working Capital for